Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > TODAY’S NUMBERS

<< Previous

Bullboard Posts

Next >>

Comment by Accountprinceon Apr 19, 2024 7:00am

242 Views

Post# 35997525

RE:RE:TODAY’S NUMBERS

Definitely financing coming. The options initially disclosed last week to Seto (1,013,377) and Kellum (506,688) have now been set at an exercise price of $0.41 each as of April 18, 2024.

Why over a week ro establish the exercise price? We'll see very soon is my guess. Given the number of options and RSU's given to each of them these essentially replace to total of 3,000,000 PSU's that expired recently as the milestones were not achieved.

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program